Skip to content

Treatment of Medial Epicondyle Fractures in Children and Adolescents

Multi-center Comparative Study of Operative Vs Nonoperative Treatment of Medial Epicondyle Fractures in Children and Adolescents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04531085
Enrollment
72
Registered
2020-08-28
Start date
2019-08-30
Completion date
2024-08-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medial Epicondyle Fracture of the Humerus, 7 To16 Year Old Children and Adolecents, More Than 2 Mm of Displacement

Brief summary

Cast immobilization in situ versus open reduction and internal fixation of displaced medial epicondyle fractures in children between 7 and 16 years old. A non-inferiority randomized controlled trial.

Detailed description

This is a multicenter, controlled, prospective, randomized non-inferiority study comparing operative treatment to non-operative treatment of over 3 mm dislocated pediatric medial epicondyle fractures without joint incarceration or ulnar nerve dysfunction. A total of 120 patients will be randomized in 1:1 ratio to either operative or non-operative treatment. The study will have a parallel non-randomized patient preference arm. Non-operative treatment will be upper limb immobilization with long arm cast for 4 weeks. Operative treatment will be open reduction and internal fixation (ORIF). Data is collected at baseline and at each follow-up up to 2 years. Quick-DASH is used as primary outcome measure. Secondary outcomes are patient reported pain, differences in range of motion, PedsQL Life inventory questionnaire as well as Mayo elbow preformance score.

Interventions

Surgery

PROCEDURELong arm cast

cast immobilization

Sponsors

Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

Non-inferiority RCT 1:1 ratio

Eligibility

Sex/Gender
ALL
Age
7 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

\- Over 2 mm displaced medial epicondyle fracture of humerus on primary AP or lateral X-ray

Exclusion criteria

* Ulnar nerve dysfunction * Pathological fracture * Open fracture * Systemic bone disease * Concomitant fracture or injury of the same upper limb requiring operative intervention * Other disease preventing participation in full follow-up regime or range of motion exercises

Design outcomes

Primary

MeasureTime frameDescription
Quick Disabilities of the Arm, Shoulder and Hand score questionnaire(QuickDASH)12 monthsMinimum value is 0 and maximum 100. Higher value indicates worse function. Statistically significant difference in QuickDASH score is 6.8 (18) at 12 months FU.

Secondary

MeasureTime frameDescription
Measurement Model for the Pediatric Quality of Life Inventory questionnaire (PedsQL)12 monthsMinimum score is 0 and maximum 100. Higher score indicates better health related quality of life.
Measurement Model for the Pediatric Quality of Life Inventory Pediatric Pain Questionaire (PEDS QL PPQ)12 monthsMinimum score 0 maximum 10. Higher value indicates higher pain intensity.
Cosmetic Visual Analoque Scale (CVAS)12 monthsMinimum score 0 maximum 100. Higher value indicates better cosmetic appearance
Range of Motion (ROM) degrees difference of the elbow as compared to uninjured arm12 monthsDifference in active ROM in comparison to uninjured arm. Maximum value is 160 degrees minimum 0. Lower value indicates better outcome.
Need for additional procedures (number)12 monthsMinimum value 0, no maximum value. Lower value indicates better outcome.
Grip strength (kg) with hand held dynamometer (jamar)12 monthscompared to standard for age kg/age
Sensation and cold intolerance12 monthssemmes-weinstein monofilaments scored as normal or abnormal
Mayo Elbow Performance Score (MEPS)12 monthsMinimum score 0 maximum 100. Higher value indicates better performance.

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026